Title |
Development of Paramyosin as a Vaccine Candidate for Schistosomiasis
|
---|---|
Published in |
Frontiers in immunology, July 2015
|
DOI | 10.3389/fimmu.2015.00347 |
Pubmed ID | |
Authors |
Mario A. Jiz, Haiwei Wu, Remigio Olveda, Blanca Jarilla, Jonathan D. Kurtis |
Abstract |
Schistosomiasis, caused by three principal species of diecious trematodes (flatworms), currently afflicts over 250 million individuals, results in an estimated 2-15% chronic disability, and contributes to poor health and economic stagnation in endemic areas. Although schistosomiasis is effectively treated with praziquantel, rapid reinfection with rebound morbidity precludes effective control based on chemotherapy alone and justifies current efforts to develop vaccines for these parasites. Paramyosin (Pmy), an invertebrate muscle-associated protein, has emerged as a promising vaccine candidate for both Schistosoma mansoni and Schistosoma japonicum. Herein, we discuss the discovery of Pmy, its development as a vaccine candidate in rodents and bovines, as well as studies of naturally occurring immune responses to Pmy in prospective, observational human studies. We conclude with a proposed developmental plan to move Pmy toward Phase I clinical trials. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 20% |
Belgium | 1 | 20% |
Switzerland | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 2% |
Unknown | 45 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 17% |
Student > Ph. D. Student | 7 | 15% |
Researcher | 6 | 13% |
Student > Bachelor | 4 | 9% |
Student > Doctoral Student | 3 | 7% |
Other | 11 | 24% |
Unknown | 7 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 11 | 24% |
Biochemistry, Genetics and Molecular Biology | 7 | 15% |
Immunology and Microbiology | 6 | 13% |
Medicine and Dentistry | 4 | 9% |
Mathematics | 2 | 4% |
Other | 5 | 11% |
Unknown | 11 | 24% |